Insightec specializes in the innovative application of incisionless focused ultrasound technology, particularly through its Exablate Neuro platform. This advanced medical technology utilizes acoustic energy to precisely target and treat specific areas in the brain, such as the thalamic nucleus, which is crucial for tremor control. The procedure is guided by real-time MRI imaging, allowing for patient-specific treatment planning and continuous monitoring of temperature to ensure safety and efficacy. This method offers immediate therapeutic effects with minimal complications, enabling patients to often return home the same day after treatment.

The focused ultrasound technology developed by Insightec is particularly beneficial for patients suffering from medication-refractory Essential Tremor and Tremor-Dominant Parkinson’s Disease. By providing a non-invasive alternative to traditional surgical methods, this technology not only enhances patient care but also transforms the landscape of neurosurgery. The precision of the treatment, which can be adjusted to meet individual patient needs, underscores the potential of focused ultrasound to significantly improve the quality of life for those affected by these conditions.

Israel

INSIGHTEC Ltd. is a global healthcare company that specializes in creating the next generation of patient care by harnessing the therapeutic power of acoustic energy. The company was founded in 1999 by GE Healthcare and Elbit Medical Imaging to bring MRI-guided focused ultrasound technology to the market. INSIGHTEC's technology uses sound waves to precisely target and ablate tissue with no incisions, minimal risk of infection, and often allows patients to undergo treatment on an outpatient basis.

Insightec

Company Details